Attention Joslin Patients:

Joslin Diabetes Center's COVID-19 pandemic hybrid care model allows patients to tailor their care with remote and in-person services, including telehealth visits. Please visit our main COVID-19 page for all this information in both English and Spanish. Please access COVID Pass the day of any on-site appointment to answer screening questions to receive a pass. 
 

Currently, Joslin does not have a supply of COVID-19 vaccine.  Vaccine availability and distribution are controlled by federal and state authorities. If the vaccine becomes available to us, Joslin will adhere to the state's plan for prioritized distribution. Please monitor the COVID-19 page on our website for updates.

Alert Close

Osama Hamdy, MD, PhD, interests include diabetes and obesity, metabolic syndrome and obesity and cardiovascular disease. His work focuses on understanding metabolic and cardiovascular benefits of lifestyle changes and weight loss. He studies the cardiovascular benefits of short- and long-term weight reduction in obese individuals with and without type 2 diabetes. Dr. Hamdy and colleagues’ research led to the discovery that obese adults who lost just 7 percent of their initial weight—the equivalent of 16 pounds in a 225-pound woman—had significant improvement of their vascular endothelial function. This improvement may eventually prevent progression of atherosclerosis, coronary artery disease and the subsequent risk of heart attack and stroke.

Dr. Hamdy is a Co-Investigator of two landmark studies: the national Diabetes Prevention Program and the Look AHEAD (Action for Health in Diabetes) Study. Dr. Hamdy translated the successful clinical research results of these lifestyle modifications studies into a clinical practice model through the creation of Joslin’s Why WAIT? (Weight Achievement and Intensive Treatment) Program, the world’s first clinical practice program designed to help patients with diabetes lose weight through a novel multidisciplinary approach. Participants in the Why WAIT? Program have lost 10 percent of their initial weight over 12 weeks and maintained that weight loss. Why WAIT? participants showed significant improvement in diabetes control, lipid, kidney and liver profiles, together with improved quality of life and physical fitness. Participants were also able to cut their diabetes medications by approximately 50 percent.

Dr. Hamdy chaired the task force that developed Joslin’s new Clinical Nutrition Guidelines and is a member of the Nutrition Guidelines Committee of the American Association of Clinical Endocrinologists that created the AACE Nutrition Guidelines for Americans 2006.

College
University of Mansoura, Egypt

Graduate School
MSc Internal Medicine,University of Mansoura, Egypt
PhD Endocrinolgy,University of Mansoura, Egypt

Internship
Internship in Internal Medicine, Department of Internal Medicine, Mansoura University Hospital, Mansoura, Egypt

Residency
Residency in Internal Medicine, Mansoura University Hospital, Mansoura, Egypt

Fellowship
Clinical Fellowship, Endocrinology, Diabetes and Metabolism, Joslin Diabetes Center/BIDMC

  • Adult

Contact Information

Office Phone

(617) 309-2645

osama.hamdy [at] joslin.harvard.edu

News Related to Osama Hamdy

Joslin Physicians on Boston Magazine's Top Docs List

Eleven of Joslin's physicians have made Boston Magazine’s 2021 Top Doctors List. Each year, Boston Magazine partners with healthcare researcher Castle Connolly Medical Ltd. to create a list of the...
Read more on Joslin Physicians on Boston Magazine's Top Docs List
Why Wait Group 2020

15th Anniversary of Why WAIT program

15th Anniversary of Why WAIT program

This week marks the 15th anniversary of Joslin’s Why WAIT program, one of the longest-running programs in Joslin’s history. Why WAIT started on September 28th, 2005 as the world’s first...
Read more on 15th Anniversary of Why WAIT program